|Bid||26.08 x 800|
|Ask||26.03 x 800|
|Day's range||25.94 - 26.43|
|52-week range||19.93 - 40.82|
|Beta (3Y monthly)||0.69|
|PE ratio (TTM)||N/A|
|Earnings date||5 Feb 2020 - 10 Feb 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||25.42|
Mednax (MD) delivered earnings and revenue surprises of 0.00% and 1.75%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.
Mednax (MD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.
Universal Health (UHS) is likely to have benefited from strong segmental performances at Acute Care and Behavioral Health in Q3, partly offset by high costs.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
Today we'll evaluate MEDNAX, Inc. (NYSE:MD) to determine whether it could have potential as an investment idea. To be...
Mednax (MD) delivered earnings and revenue surprises of 2.30% and 0.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?